TRANSFUSION AND APHERESIS SCIENCE, vol.50, no.1, pp.53-55, 2014 (SCI-Expanded)
Background: Granulocyte-colony stimulating factor (G-CSF) is widely administered to donors who provide peripheral blood stem cells (PBSCs) for individuals who undergo hematopoietic stem cell transplants. G-CSF administration is associated with a small but definite risks of serious adverse events like splenic rupture.